Status:
NOT_YET_RECRUITING
"Matrix Metalloproteinases 7 and 9 in Rheumatoid Arthritis Patients With Interstitial Lung Disease"
Lead Sponsor:
Assiut University
Conditions:
Rheumatoid Arthritis (RA)
Eligibility:
All Genders
18+ years
Brief Summary
This case control study will be done at Rheumatology Department, Assiut University Hospital. It will include RA patients fulfilling the American College of Rheumatology and European League against Rhe...
Detailed Description
Introduction Rheumatoid arthritis (RA) is a systemic inflammatory disorder most commonly affects the joints, causing progressive, symmetric, erosive destruction of cartilage and bone, usually associat...
Eligibility Criteria
Inclusion
- 1- Age \>18. 2- RA diagnosis according (ACR / EULAR) 2010.
Exclusion
- Age \<18 years.
- Other connective tissue diseases (systemic sclerosis, systemic Lupus and Mixed connective tissue disease)
- Malignancy
- Another chest presentation
- Patient refuse
- Patients with recent nail trauma
- Patients with heavy manual activities
- Poor nailfold hygiene
- Congestive heart failure
- Individuals unable to cooperate during the nailfold capillaroscopic examination.
Key Trial Info
Start Date :
October 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2027
Estimated Enrollment :
81 Patients enrolled
Trial Details
Trial ID
NCT07173582
Start Date
October 1 2025
End Date
April 1 2027
Last Update
September 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assuit University
Asyut, Egypt, 71111